Skip to content

Travel to Work study

The effectiveness and cost-effectiveness of an employer-led intervention to increase walking during the daily commute: a cluster randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15009100
Enrollment
672
Registered
2014-12-10
Start date
2015-03-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical activity Not Applicable

Interventions

There are three main stages of the intervention: 1. Workplace ‘Walk to Work promoters’ will be identified (volunteers, or nominated by participating employers, with an interest in walk
barriers and solutions discussed, and safe, feasible routes identified. Goals for incorporating walking into the journey to and from work will be set. 3. Further encouragement will be

Sponsors

University of Bristol
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Employees: 1. Of any age and gender 2. In small, medium and large workplaces 2. In Bath, Swansea and South Gloucestershire

Exclusion criteria

Exclusion criteria: 1. Employees who always walk or cycle to work 2. Employees who are disabled in relation to walking to work, and employees whose job involves regular driving throughout the day (for example, delivery drivers or sales representatives who set off from home in the work vehicle) 3. Organisations with little direct communication between senior management and employees are not suited to this intervention (unless there is a local supervisor/manager with the authority to agree the study activities) because of the need for employer support for recruitment of participants and Walk to Work promoters 4. Workplaces with a large proportion of staff on short-term or zero-hours contracts are not suited because of the need for a one-year follow-up data collection 5. Employees who are retiring before the one-year follow-up data collection 6. Workplaces with firm plans to significantly downsize or relocate during the study period

Design outcomes

Primary

MeasureTime frame
Daily minutes of moderate to vigorous physical activity (MVPA), measured using accelerometers at baseline and one-year follow-up

Secondary

MeasureTime frame
Physical activity: 1. Overall levels of physical activity (cpm), measured using accelerometers 2. Daily minutes of sedentary time 3. Modal shift (number of days, over the previous five working days, when walking was the major mode of travel to/from work) Process outcomes: 1. Facilitators and barriers to workplace/employer participation in Walk to Work interventions 2. Facilitators and barriers to employees walking during the daily commute 3. Physical activity/MVPA due to walking during the journey to/from work Economic evaluation outcomes: 1. Costs to employers, employees and the public sector of implementing the Walk to Work scheme 2. Consequences for the employer; absenteeism/presenteeism 3. Consequences for employees; commuting costs and wellbeing 4. Consequences for the public sector; health service use

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 18, 2026